SK Hynix Makes Historic $26.5 Billion Nasdaq Debut, Largest Foreign U.S. Listing Ever
Oversubscribed 7x amid surging AI demand for HBM chips.
Already have an account? Sign in.
Oversubscribed 7x amid surging AI demand for HBM chips.
Shares of Aardvark Therapeutics dropped after limited HERO data showed only temporary benefit for ARD-101 in Prader-Willi syndrome, delaying restart to 2027.
BDR Pharmaceuticals has sued the FDA over its decision to extend VOQUEZNA’s new chemical entity exclusivity through May 2032 under the GAIN Act.
Updated Phase 1/2 data at ESMO showed 82% ORR and 88% 9-month PFS with vopimetostat plus daraxonrasib in previously treated MTAP-deleted RAS-mutant PDAC.
Be the first to know when deals break, stocks move, or biotech headlines hit.